Fri, July 8, 2022

Robert Driscoll Initiated (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022

Robert Driscoll of Wedbush, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022.

Robert has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, all agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Fein of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $40 on, Wednesday, March 16th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $80 on, Wednesday, March 16th, 2022